Medical Pharmaceuticals

CND Life Sciences Receives Accreditation from the College of American Pathologists

by

SCOTTSDALE, Ariz., June 16, 2023 /PRNewswire/ — CND Life Sciences, a medical technology company pioneering the development of skin-based tests to help clinicians diagnose neurodegenerative diseases and other neurologic disorders, has been awarded accreditation by the College of American Pathologists (CAP). Recognized for rigorous and robust standards, CAP accreditation elevates quality in important ways so … Read more

TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody

by

HEFEI, China, June 16, 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of TGI-6, its groundbreaking bispecific antibody. TGI-6 targets unique tumor-associated antigens (TAA) and CD3 molecules simultaneously, enabling … Read more

Fibromyalgia Treatment Market to Reach $4.6 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research

by

The fibromyalgia treatment market is experiencing growth due to several key factors, such as the significant prevalence of fibromyalgia among the population, a surge in awareness regarding fibromyalgia and its treatment, and enhanced access to generic medications for fibromyalgia treatment. PORTLAND, Ore., June 16, 2023 /PRNewswire/ — Allied Market Research published a report titled, “Fibromyalgia Treatment … Read more

The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer

by

NANJING, China, June 16, 2023 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs” or “Company”) today announces that the phase I/II clinical trial application for LBL-033, an anti-MUC16/CD3 bispecific antibody, for the treatment of ovarian cancer and other malignant tumors, has been approved by the FDA (U.S. Food and Drug Administration). At … Read more

Apollo Hospitals Eliminates 2,90,000 Tons of Carbon with Smart Joules, Strengthening India’s Decarbonization Efforts

by

NEW DELHI, June 16, 2023 /PRNewswire/ — Apollo Hospitals, the world’s largest vertically integrated healthcare provider, has joined hands with Smart Joules to reduce carbon emissions by an astounding 2,90,000 tons, bolstering India’s efforts to decarbonize. This ten-year initiative spans 18 hospitals across the nation and leverages the ground-breaking JoulePAYS solution by Smart Joules for energy-efficient … Read more

Increasing Cases of Human Papillomavirus Diseases Drive Growth

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Human Papillomavirus Vaccine Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication, By Distribution Channel, By Company and By Region” report has been added to ResearchAndMarkets.com’s offering. The global human papillomavirus vaccine market is anticipated to observe … Read more

Studie zeigt Auswirkungen der Luftverschmutzung auf die Atemwege von Elitesportlern in der frühen Karriere

by

HAMBURG, Deutschland, 16. Juni 2023 /PRNewswire/ — Eine kürzlich in Belgien durchgeführte Studie hat die potenziellen Auswirkungen der Luftverschmutzung auf die Atemwege von Spitzensportlern in ihrer Frühkarriere aufgezeigt. Während körperliche Betätigung bekanntermaßen die allgemeine Gesundheit verbessert, deutet die Studie darauf hin, dass intensive körperliche Aktivität in einer verschmutzten Umgebung als Stressfaktor für die Atemwegsbarriere wirken … Read more

NABR reicht Petition zur Anfechtung der Aufnahme des Langschwanzmakaken (Long-Tailed Macaque) in die Liste der IUCN ein

by

WASHINGTON, 16. Juni 2023 /PRNewswire/ — In Zusammenarbeit mit anerkannten, unabhängigen Wissenschaftlern reichte die National Association for Biomedical Research (NABR) heute eine Petition bei der International Union for Conservation of Nature (IUCN) ein, in der sie die jüngste Einstufung des Langschwanzmakaken (Cynomolgus macaque) nach den Kriterien der IUCN als gefährdet anzweifelt. Diese Einstufung ist das … Read more

EW Group signe un accord avec Sinopharm, la plus grande entreprise de soins de santé de Chine

by

PETALING JAYA, Malaisie, 16 juin 2023 /PRNewswire/ — European Wellness Biomedical Group (EW Group) a annoncé son partenariat avec HK VJM Ltd (représentant Sinopharm Cloud Health Technology (Guandong) Co. et Sinopharm Traditional Chinese Medicine (Foshan) Co.) et NCL Solutions Sdn Bhd le 15 avril 2023 au One World Hotel. EW Group était représenté par son président, Prof. Dato Sri Dr. Mike Chan, et HK VJM Ltd par M. Guo Liang, tandis que NCL Solutions Sdn Bhd était représenté par Mme Cindy Chong Seau Joon. EW Group fournira son expertise et son expérience … Read more

Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023

by

SUNNYVALE, Calif., June 15, 2023 /PRNewswire/ — The global Accuray Incorporated (NASDAQ: ARAY) team is proud to announce that president and CEO Suzanne Winter has been recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology CEOs of 2023. This year’s awardees, some of the most accomplished executives in the industry, represent … Read more